The contemporaneous presence of immune defects and heart diseases in patients with 22q11.2 deletion syndrome (22q11.3DS) might represent risk factors for severe coronavirus 2019 disease (COVID-19).
COVID-19 Severity, Cardiological Outcome, and Immunogenicity of mRNA Vaccine on Adult Patients With 22q11.2 DS / Pulvirenti, Federica; Mortari, Eva Piano; Putotto, Carolina; Terreri, Sara; Fernandez Salinas, Ane; Cinicola, Bianca Laura; Cimini, Eleonora; Di Napoli, Giulia; Sculco, Eleonora; Milito, Cinzia; Versacci, Paolo; Agrati, Chiara; Marino, Bruno; Carsetti, Rita; Quinti, Isabella. - In: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. IN PRACTICE. - ISSN 2213-2198. - (2022). [10.1016/j.jaip.2022.10.010]
COVID-19 Severity, Cardiological Outcome, and Immunogenicity of mRNA Vaccine on Adult Patients With 22q11.2 DS
Mortari, Eva Piano;Putotto, Carolina;Cinicola, Bianca Laura;Di Napoli, Giulia;Sculco, Eleonora;Milito, Cinzia;Versacci, Paolo;Marino, Bruno;Quinti, Isabella
2022
Abstract
The contemporaneous presence of immune defects and heart diseases in patients with 22q11.2 deletion syndrome (22q11.3DS) might represent risk factors for severe coronavirus 2019 disease (COVID-19).| File | Dimensione | Formato | |
|---|---|---|---|
|
del22Covid.pdf
accesso aperto
Note: Pulvirenti_COVID-19 Severity_2022
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
1.87 MB
Formato
Adobe PDF
|
1.87 MB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
